END-VOC Publications
2025
Perehudoff, Katrina, Pramiti Parwani, and Seraphine Bruinsma. Advancing vaccines justice through international regulatory pathways. Global Public Health 20.1 (2025): 2566730. https://doi.org/10.1080/
Perehudoff, Katrina. EU’s Extraterritorial Obligations for Global Medicine Access Under the Convention on the Rights of Persons with Disability (CPRD). Journal of Law, Medicine & Ethics 53.3 (2025): 356-364. https://doi.org/10.1017/jme.
Estill J, Belayneh EG, Beale S, Keiser O. Estimation of the number of people affected by post COVID-19 condition in Switzerland in 2023: a mathematical model. Int J Infect. Dis. (2025) doi: 1016/j.ijid.2025.107963
Ranzani O., Martín Pérez C., Rubio R. et al. Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort. Nat Commun (2025). https://doi.org/10.1038/s41467-025-67577-9
Blay N, Farré X, Garcia-Aymerich J, Castaño-Vinyals G, Kogevinas M, de Cid R. Pre-pandemic disease trajectories and genetic insights into long COVID susceptibility. BMC Medicine 23, 590 (2025). DOI: doi.org/10.1186/s12916-025-04427-x
Farré X, Blay N, Iraola-Guzmán S et al. VEGFA sex-specific signature is associated to long COVID symptom persistence. BMC Med. October 2025. doi:10.1186/s12916-025-04402-6.
Fama F, Fattore R, Raimondo P et al. The impact of SARS-CoV-2 VOCs on clinical outcomes: an overview of reviews. Front. Med. August 2025. doi:10.3389/fmed.2025.1624459.
Lammi V, Nakanishi T, Jones SE et al. Genome-wide association study of long COVID. Nat Genet. 2025. doi:10.1038/s41588-025-
Lovaglio PG, Borgonovo F, Margiotta AM et al. Estimating Long COVID-19 prevalence across definitions and forms of sample selection. Front. Epidemiol. May 2025. doi:10.3389/fepid.2025.1597799.
Borges IC, Lino FM, Luna-Muschi A et al. TB as a risk factor for severe COVID-19 mortality. Int J Tuberc Lung Dis. April 2025. doi: 10.5588/ijtld.24.0503.
Beale, S., Yavlinsky, A., Moncunill, G. et al. Anti-nucleocapsid and anti-spike antibody trajectories in people with post-covid condition versus acute-only infections: a nested longitudinal case-control study within the Virus Watch prospective cohort. Nat Commun. April 2025. doi:10.1038/s41467-025-58766-7.
Molinos-Albert L, Rubio R, Martín-Pérez C et al. Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic. Cell Reports. April 2025. DOI: 10.1016/j.celrep.2025.115498.
Martín-Pérez C, Ruiz-Rius S, Ramírez-Morros A et al. Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections. J Infection. March 2025. DOI: 10.1016/j.jinf.2025.106473
Kogevinas, M., Karachaliou, M., Espinosa, A…. Dobaño, C., Moncunill, G., de Cid, R., & Garcia-Aymerich, J. Risk, Determinants and Persistence of long-COVID in a Population-Based Cohort Study in Catalonia. BMC Medicine. March 2025. Doi: 10.1186/s12916-025-03974-7
Rubio R, Yavlinsky A, Escalera-Zamudio M… Dobaño C, Moncunill G. Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later. J of Infection. Feb 2025. DOI: 10.1016/j.jinf.2024.106402
2024
Colaneri M, Fama F, Fassio F et al. Impact of early antiviral therapy on SARS-CoV-2 clearance time in high-risk COVID-19 subjects: A propensity score matching study. 2024. Int J Infect Dis. 10.1016/j.ijid.2024.107265
Raddad Y, Hasasneh A, Abdallah O, Rishmawi C, Qutob N. Integrating Statistical Methods and Machine Learning Techniques to Analyze and Classify COVID-19 Symptom Severity. Big Data Cogn. Comp. Dec 16, 2024. Doi: 10.3390/bdcc8120192.
Abubakar I, Lutwana J, Kyobutungi C, Sankoh O. Mpox Global emergency: strengthening African leadership. The Lancet. Sept 20, 2024. Doi:10.1016/S0140-6736(24)02068-3.
Rubio R, Macià D, Barrios D … Moncunill G, Dobaño C. High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination. Microbes Infect. 2024 Sep 17:105423. doi: 10.1016/j.micinf.2024.105423
Karachaliou M, Ranzani O, Espinosa A … Moncunill G, Kogevinas M. Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19. J Med Virol. 2024 Sep;96(9):e29862. doi: 10.1002/jmv.29862.
Azambuja P, Bastos LSL, Batista-da-Silva AA, Viana Ramos G, Kurtz P, Dias CMC, da Silva EP, Arouca LE, Soares J, Sejvar JJ, Sigfrid LL, Ranzani OT, Hamacher S, Bozza FA. Prevalence, risk factors, and impact of long COVID in a socially vulnerable community in Brazil: a prospective cohort study. The Lancet Reg Health. July 17, 2024. doi: 10.1016/j.lana.2024.100839.
Lazar, F., Mercadé-Besora N., Raventós B., Pérez-Crespo L., Castro G., Ranzani O., Duarte-Salles T. Effectiveness of COVID-19 Vaccines Against Severe COVID-19 Among Patients with Cancer in Catalonia, Spain. Nature Communications. 2024. https://doi.org/10.1038/s41467-024-49285-y
Aguilar R, Jiménez A, Santano R et al. Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings. J Med Virol. 2024 Jun;96(6):e29713. doi: 10.1002/jmv.29713.
Cedric CS Tan, Lucy van Dorp and François Balloux. The evolutionary drivers and correlates of viral host jumps. Nat Ecol Evol .2024. doi:10.1038/s41559-024-02353-4.
Martin Perez C, Aguilar R, Jiménez A et al. Correlates of protection and determinants of SARS-CoV-2 breakthrough infections one year after third dose vaccination. BMC Med. 2024. doi:10.1186/s12916-024-03304-3.
Sarah Beale, Alexei Yavlinsky, Wing L E Fong, Vincent G Nguyen, Jana Kovar, Theo Vos, Sarah Wulf Hanson, Andrew C Hayward, Ibrahim Abubakar, Robert W Aldridge. Long-term outcomes of SARS-CoV-2 variants and other respiratory infections: evidence from the Virus Watch prospective cohort in England. Epidemiol Infect. 2024 May 10:152:e77. doi: 10.1017/S0950268824000748.
Holmes D, Colaneri M, Palomba E, Andrea Gori. Exploring post-SEPSIS and post-COVID-19 syndromes: crossovers from pathophysiology to therapeutic approach. Front. Med., 05 January 2024. Doi: 10.3389/fmed.2023.1280951
Wing Lam Erica Fong, Vincent Grigori Nguyen, Sarah Beale, Thomas E Byrne, Cyril Geismar, Ellen Fragaszy, Jana Kovar, Annalan M D Navaratnam, Alexei Yavlinsky, Ibrahim Abubakar, Andrew C Hayward, Robert W Aldridge. Tracking COVID-19 in England and Wales: Insights from Virus Watch – a prospective community cohort study. J Infect Dis Epidemiol. 2024, 10:314. Volume 10 | Issue 1. DOI: 10.23937/2474-3658/1510314
Saucy A, Espinosa A, Iraola-Guzman S, Castano-Vinyals G et al. Environmental Exposures and Long COVID in a Prospective Population-Based Study in Catalonia (COVICAT Study). Environ Health Perspect. 2024. doi: 10.1289/EHP15377
2023
Thomas Byrne, Jana Kovar, Sarah Beale, Isobel Braithwaite, Ellen Fragaszy, Wing Lam Erica Fong, Cyril Geismar, Susan Hoskins, Annalan M D Navaratnam, Vincent Nguyen, Parth Patel, Madhumita Shrotri, Alexei Yavlinsky, Pia Hardelid, Linda Wijlaars, Eleni Nastouli, Moira Spyer, Anna Aryee, Ingemar Cox, Vasileios Lampos, Rachel A Mckendry, Tao Cheng, Anne M Johnson, Susan Michie, Jo Gibbs, Richard Gilson, Alison Rodger, Ibrahim Abubakar, Andrew Hayward, Robert W Aldridge. Cohort Profile: Virus Watch—understanding community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviour. International Journal of Epidemiology, Volume 52, Oct 2023, e263–e272. Doi: 10.1093/ije/dyad087
Marta Canuti, Maria Cristina Monti, Chiara Bobbio, Antonio Muscatello, Toussaint Muheberimana, Sante Leandro Baldi, Francesco Blasi, Ciro Canetta, Giorgio Costantino, Alessandro Nobili, Flora Peyvandi, Mauro Tettamanti, Simone Villa, Stefano Aliberti, Mario C Raviglione, Andrea Gori, Alessandra Bandera; COVID-19 Network Study Group. The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic. Front Med. 2023 Sep 7:10:1260950. doi: 10.3389/fmed.2023.1260950. eCollection 2023.
Tan CCS, Trew J, Peacock TP, Mok KY, Hart C, Lau K, Ni D, Orme CDL, Ransome E, Pearse WD, Coleman CM, Bailey D, Thakur N, Quantrill JL, Sukhova K, Richard D, Kahane L, Woodward G, Bell T, Worledge L, Nunez-Mino J, Barclay W, van Dorp L, Balloux F, Savolainen V. Genomic screening of 16 UK native bat species through conservationist networks uncovers coronaviruses with zoonotic potential. Nat Commun. 2023 Jun 27;14(1):3322. doi: 10.1038/s41467-023-38717-w.
Kuchipudi SV, Tan C, van Dorp L, Lichtveld M, Pickering B, Bowman J, Mubareka S, Balloux F. Coordinated surveillance is essential to monitor and mitigate the evolutionary impacts of SARS-CoV-2 spillover and circulation in animal hosts. Nat Ecol Evol. 2023 Jul;7(7):956-959. doi: 10.1038/s41559-023-02082-0.
